Boenning & Scattergood’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $1.88M | Buy |
43,255
+5,813
| +16% | +$253K | 0.3% | 87 |
|
|
2022
Q3 | $1.1M | Buy |
37,442
+7,910
| +27% | +$233K | 0.23% | 114 |
|
|
2022
Q2 | $1.61M | Sell |
29,532
-5,072
| -15% | -$276K | 0.3% | 83 |
|
|
2022
Q1 | $1.88M | Sell |
34,604
-11,164
| -24% | -$608K | 0.3% | 87 |
|
|
2021
Q4 | $2.52M | Sell |
45,768
-2,292
| -5% | -$126K | 0.4% | 61 |
|
|
2021
Q3 | $2.3M | Buy |
48,060
+4,096
| +9% | +$196K | 0.4% | 61 |
|
|
2021
Q2 | $2.19M | Buy |
43,964
+7,468
| +20% | +$372K | 0.38% | 70 |
|
|
2021
Q1 | $1.63M | Buy |
36,496
+2,222
| +6% | +$99.1K | 0.31% | 91 |
|
|
2020
Q4 | $1.58M | Buy |
34,274
+1,552
| +5% | +$71.4K | 0.33% | 84 |
|
|
2020
Q3 | $1.54M | Sell |
32,722
-1,540
| -4% | -$72.5K | 0.37% | 70 |
|
|
2020
Q2 | $1.75M | Sell |
34,262
-4,797
| -12% | -$245K | 0.47% | 54 |
|
|
2020
Q1 | $1.85M | Sell |
39,059
-1,102
| -3% | -$52.2K | 0.64% | 39 |
|
|
2019
Q4 | $2.36M | Buy |
40,161
+14,632
| +57% | +$859K | 0.61% | 43 |
|
|
2019
Q3 | $1.36M | Buy |
25,529
+44
| +0.2% | +$2.35K | 0.39% | 67 |
|
|
2019
Q2 | $1.28M | Buy |
25,485
+135
| +0.5% | +$6.75K | 0.37% | 77 |
|
|
2019
Q1 | $1.32M | Sell |
25,350
-18,699
| -42% | -$977K | 0.4% | 72 |
|
|
2018
Q4 | $2.1M | Buy |
44,049
+18,294
| +71% | +$874K | 0.73% | 30 |
|
|
2018
Q3 | $1.29M | Sell |
25,755
-46
| -0.2% | -$2.31K | 0.41% | 66 |
|
|
2018
Q2 | $1.3M | Buy |
+25,801
| New | +$1.3M | 0.43% | 68 |
|